前收盘价格 | 30.68 |
收盘价格 | 30.63 |
成交量 | 328,640 |
平均成交量 (3个月) | 784,150 |
市值 | 916,597,504 |
市盈率 (P/E TTM) | 82.89 |
预期市盈率 (P/E Forward) | 14.62 |
价格/销量 (P/S) | 0.890 |
股市价格/股市净资产 (P/B) | 3.56 |
52周波幅 | |
利润日期 | 5 Nov 2024 - 11 Nov 2024 |
营业毛利率 | 1.16% |
营业利益率 (TTM) | 8.63% |
稀释每股收益 (EPS TTM) | 0.370 |
季度收入增长率 (YOY) | 4.60% |
季度盈利增长率 (YOY) | 61.80% |
总债务/股东权益 (D/E MRQ) | 176.93% |
流动比率 (MRQ) | 2.58 |
营业现金流 (OCF TTM) | 20.22 M |
杠杆自由现金流 (LFCF TTM) | 2.18 M |
资产报酬率 (ROA TTM) | 4.86% |
股东权益报酬率 (ROE TTM) | 5.52% |
市场趋势
短期 | 中期 | ||
行业 | Drug Manufacturers - Specialty & Generic (US) | 看跌 | 混合的 |
Drug Manufacturers - Specialty & Generic (全球的) | 看跌 | 混合的 | |
股票 | PetIQ, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
分析师共识 | -2.0 |
内部交易活动 | NA |
价格波动 | -1.5 |
技术平均移动指标 | -2.5 |
技术振荡指标 | 0.0 |
平均 | -1.50 |
PetIQ Inc is a manufacturer and distributor of health and wellness products for dogs and cats. The company offers veterinarian-grade pet Rx medications, OTC flea and tick preventatives, vitamins treats, nutritional supplements, and hygiene products. The group operates in two segments namely the Products and Services segments. It also provides third-party products to retailers which for a long time are available for veterinary clinics only. Its proprietary brands include PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, TruProfen, Betsy Farms, PetAction, Minties, Vera and Delightibles. The company generates maximum revenue from Products segment. |
|
部门 | Healthcare |
行业 | Drug Manufacturers - Specialty & Generic |
投资方式 | Small Core |
内部持股比例 | 6.94% |
机构持股比例 | 103.46% |
所有权
姓名 | 日期 | 持有股份 |
---|---|---|
Eos Management, L.P. | 30 Jun 2024 | 1,972,687 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合